M&A, Antitrust & Competition

Antitrust and Competition Expertise

We bring experienced economic experts and right-sized teams to assist clients and law firms before U.S. and international agencies and courts – for privileged consulting, disputes, and expert testimony on mergers, business practices, contracting, class certification, damages, and pricing.

Economic Analyses of M&A

U.S & International: We analyze competitive effects and consumer benefits on hospitals, physicians, devices and pharmaceuticals from pre-merger to ongoing review; our comprehensive economic analyses of potential risks and benefits of affiliations across all industry levels responds to increased antitrust scrutiny.

Regulatory Contexts: CON, COPA, Market Inquiry

We provide comprehensive economic analyses on benefits, risks or conditions to advise clients on Certificate of Need (CON) or Certificate of Public Advantage (COPA) cases and assist clients in government market inquiries (e.g., South Africa Competition Commission Health Market Inquiry).
Benefits of Transformational Change and Consulting for Health Systems and Payors
We bring advanced analytics on transformational changes in infrastructure, location of care, new payment models, compliance and proactive evaluation of transactions for competitive risk and benefit. Our analyses assist clients seeking to optimize health systems with limited resources to evaluate realignment, investments, and outcomes to show value.

Economic Research, Healthcare and Industry Trends, and Modeling

We’re committed to industry and economic research and advanced economic modeling for complex merger and market situations. Our experts publish extensively in peer-reviewed literature on mergers, healthcare transformation, integrated and new care models, health economics research and participate actively in professional associations.